TNFa-producing Macrophages Determine Subtype Identity and Prognosis via AP1 Enhancer Reprogramming in Pancreatic Cancer [TNFa-treatment RNA-seq]
In pancreatic cancer, classical and basal-like subtypes are identified as two major PDAC subtypes. Our previous data showed that PDAC tumor cells can switch between the two phenotypes through transcriptional reprogramming particularly in response to inflammatory cues. In this study, we were trying to understand TNFa mediated transcription regulatory network  in pancreatic cancer. Hence, we performed RNA-seq in TNFa treated classical cells as well as aqua dest control. Overall design: RNA-seq was performed in aqua dest treated CAPAN1 control samples, as well as 18 h TNFa treated CAPAN1 cells (10 ng/ul). Three biological repeats were used in each group.